Correlation Between Ko Ja and Lotus Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Ko Ja and Lotus Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ko Ja and Lotus Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ko Ja Cayman and Lotus Pharmaceutical Co, you can compare the effects of market volatilities on Ko Ja and Lotus Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ko Ja with a short position of Lotus Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ko Ja and Lotus Pharmaceutical.
Diversification Opportunities for Ko Ja and Lotus Pharmaceutical
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 5215 and Lotus is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Ko Ja Cayman and Lotus Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceutical and Ko Ja is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ko Ja Cayman are associated (or correlated) with Lotus Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceutical has no effect on the direction of Ko Ja i.e., Ko Ja and Lotus Pharmaceutical go up and down completely randomly.
Pair Corralation between Ko Ja and Lotus Pharmaceutical
Assuming the 90 days trading horizon Ko Ja Cayman is expected to generate 0.75 times more return on investment than Lotus Pharmaceutical. However, Ko Ja Cayman is 1.34 times less risky than Lotus Pharmaceutical. It trades about -0.18 of its potential returns per unit of risk. Lotus Pharmaceutical Co is currently generating about -0.18 per unit of risk. If you would invest 4,660 in Ko Ja Cayman on October 7, 2024 and sell it today you would lose (190.00) from holding Ko Ja Cayman or give up 4.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ko Ja Cayman vs. Lotus Pharmaceutical Co
Performance |
Timeline |
Ko Ja Cayman |
Lotus Pharmaceutical |
Ko Ja and Lotus Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ko Ja and Lotus Pharmaceutical
The main advantage of trading using opposite Ko Ja and Lotus Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ko Ja position performs unexpectedly, Lotus Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceutical will offset losses from the drop in Lotus Pharmaceutical's long position.Ko Ja vs. Holy Stone Enterprise | Ko Ja vs. Walsin Technology Corp | Ko Ja vs. Yageo Corp | Ko Ja vs. HannStar Board Corp |
Lotus Pharmaceutical vs. Chung Hsin Electric Machinery | Lotus Pharmaceutical vs. Nan Ya Printed | Lotus Pharmaceutical vs. Panion BF Biotech | Lotus Pharmaceutical vs. Adimmune Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |